Page last updated: 2024-12-08

etaden

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

etaden: Russian (alkylamino derivative of adenine); stimulates protein synthesis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID196443
SCHEMBL ID4111665
MeSH IDM0063085

Synonyms (26)

Synonym
STL287746
2-[(6-amino-9h-purin-8-yl)amino]ethanol
OPREA1_344044
etaden
ethaden
ethanol, 2-((6-amino-1h-purin-8-yl)amino)-
A835551
66813-29-4
2-[(6-amino-7h-purin-8-yl)amino]ethanol
AKOS006279185
unii-2fv7wz3u9k
2fv7wz3u9k ,
AKOS015998409
FT-0641094
8-(hydroxyethylamino)adenine
SCHEMBL4111665
DTXSID00216927
8-(2-hydroxy-ethylamino)adenine
2-(6-amino-1h-purin-8-ylamino)ethanol
2-[(6-amino-9h-purin-8-yl)amino]ethan-1-ol
2-((6-amino-9h-purin-8-yl)amino)ethanol
ethanol, 2-((6-amino-9h-purin-8-yl)amino)-
etaden [who-dd]
EN300-258660
2-[(6-amino-1h-purin-8-yl)amino]ethan-1-ol
Z3235018849
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.93 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (14.29%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]